‹‹38››. Langham WH, Bassett H, Harris PS, Carter RE. Distribution and excretion of plutonium administered intravenously to man. Los Alamos: Los Alamos Scientific Laboratory, LAB1151.
‹‹39››. Loscialpo MJ. Nontherapeutic human research experiments on institutionalized mentally retarded children: civil rights and remedies.
‹‹40››. Assistant to the Secretary of Defense for Nuclear and Chemical and Biological Defense Programs, Department of Defense. Report on search for human radiation experiment records 1944–1994. http://www.defense.gov/pubs/dodhre/. June 1997. Accessed March 12, 2015.
‹‹41››. Kouvaris JR, Kouloulias VE, Vlahos LJ. Amifostine: the first selective-target and broadspectrum radioprotector.
‹‹42››. Rao BN, Archana PR, Aithal BK, Rao BSS. Protective Effect of zingerone, a dietary compound against radiation induced genetic damage and apoptosis in human lymphocytes.
‹‹43››. Arora R, Gupta D, Chawla R, et al. Radioprotection by plant products: present status and future prospects.
‹‹44››. Malekirad AA, Ranjbar A, Rahzani K, et al. Oxidative stress in radiology staff.
‹‹45››. Zeraatpishe A, Oryan S, Bagheri MH, et al. Effects of Melissa officinalis L. on oxidative status and DNA damage in subjects exposed to long-term low-dose ionizing radiation.
‹‹46››. Zhong W, Maradit-Kremers H, St Sauver JL, et al. Age and sex patterns of drug prescribing in a defined American population.
‹‹47››. Lindsley CW. The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics.
‹‹48››. Centers for Disease Control National Center for Health Statistics. National Ambulatory Medical Care Survey: 2010 Summary Tables. http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_namcs_web_tables.pdf. 2010. Accessed March 12, 2015.
‹‹49››. Hudson B, Zarifeh A, Young L, Wells JE. Patients’ expectations of screening and preventive treatments.
‹‹50››. Lytsy P, Westerling R. Patient expectations on lipid-lowering drugs.
‹‹51››. Trewby PN, Reddy AV, Trewby CS, Ashton VJ, Brennan G, Inglis J. Are preventive drugs preventive enough? A study of patients’ expectation of benefi t from preventive drugs.
‹‹52››. Trewby PN, Reddy AV, Trewby CS, Ashton VJ, Brennan G, Inglis J. Are preventive drugs preventive enough? A study of patients’ expectation of benefi t from preventive drugs.
‹‹53››. Trewby PN, Reddy AV, Trewby CS, Ashton VJ, Brennan G, Inglis J. Are preventive drugs preventive enough? A study of patients’ expectation of benefi t from preventive drugs.
‹‹54››. Trewby PN, Reddy AV, Trewby CS, Ashton VJ, Brennan G, Inglis J. Are preventive drugs preventive enough? A study of patients’ expectation of benefi t from preventive drugs.
‹‹55››. Esselstyn CB Jr, Gendy G, Doyle J, Golubic M, Roizen MF. A way to reverse CAD?
‹‹56››. Esselstyn CB Jr, Gendy G, Doyle J, Golubic M, Roizen MF. A way to reverse CAD?
‹‹57››. Duthie GG, Wood AD. Natural salicylates: foods, functions and disease prevention.